Help Your Patients Take Charge. Managing a chronic disease can be complex and frustratingâfor. you and your patients. Give them the tools they need to improve. their health. Recommend a self-management education or physical. activity intervention and help your patients take charge.
Severe Eczema Drug Is Approved by F.D.A.; Price Tag Is $37,000 a Year. Debbie Byrnes suffered from severe eczema, but her skin is almost completely clear after using Dupixent for two years. The Food and Drug Administration on Tuesday approved a drug to treat people with a serious form of eczema, a potential breakthrough for people who have suffered for years without relief.
Now, a new entrant may become the focal point of controversy. This morning, Seattle Genetics disclosed that the annual cost for Adcetris, which the FDA approved late last week to combat Hodgkinâs disease and another rare lymphoma, will cost $13,500 per dose. In clinical trials, patients received an average of eight infusions, which works out to $108,000 a year, which Xconomy reports was in line with several Wall Street estimates.